- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 9/78 - Hydrolases (3.) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Patent holdings for IPC class C12N 9/78
Total number of patents in this class: 1221
10-year publication summary
34
|
34
|
58
|
64
|
89
|
104
|
139
|
182
|
155
|
117
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
President and Fellows of Harvard College | 5838 |
83 |
Beam Therapeutics Inc. | 190 |
82 |
The Broad Institute, Inc. | 1637 |
68 |
Massachusetts Institute of Technology | 9834 |
38 |
The Regents of the University of California | 19150 |
29 |
National University Corporation Kobe University | 478 |
22 |
The General Hospital Corporation | 4572 |
19 |
PureTech Scientific LLC | 36 |
15 |
Spogen Biotech Inc. | 121 |
14 |
Zhejiang University of Technology | 207 |
14 |
BASF SE | 20070 |
12 |
DSM IP Assets B.V. | 5838 |
11 |
The Trustees of the University of Pennsylvania | 4179 |
10 |
CJ Cheiljedang Corporation | 3106 |
10 |
Duke University | 2920 |
9 |
Polaris Group | 16 |
9 |
Pairwise Plants Services, Inc. | 197 |
9 |
Amano Enzyme Inc. | 343 |
8 |
Fukuoka University | 126 |
8 |
Illumina, Inc. | 2890 |
8 |
Other owners | 743 |